Illustration of the Disulfide bond formulation in the vaccine.

Illustration of the Disulfide bond formulation in the vaccine.

<p>(A) The vaccine preliminary 3-D structure; (B) Represents the modified vaccine design (based on disulfide bonds formulation); small yellow rods show bond creation.</p>

Saved in:

Bibliographic Details
Main Author:	Saurav Kumar Mishra (13228369) (author)
Other Authors:	Kanishka Sithira Senathilake (20797077) (author), Neeraj Kumar (109718) (author), Chirag N. Patel (4722756) (author), Mohammad Borhan Uddin (20797080) (author), Taha Alqahtani (12855941) (author), Ali Alqahtani (7039244) (author), Hanan M. Alharbi (17357516) (author), John J. Georrge (4722759) (author)
Published:	2025
Subjects:	Medicine Microbiology Molecular Biology Biotechnology Immunology Infectious Diseases Virology Biological Sciences not elsewhere classified severe health issue prospective physiochemical characteristics mol binding energy immunological evaluation demonstrated igm +&# 8201 identified one b human immunodeficiency virus conjoined concurrently using 284 amino acids 1 envelope glycoprotein strong molecular interaction gpgpg ), including epitope subunit vaccine developed vaccine stimulates designed vaccine expression robust immune response immune response aids ), specific vaccine immune reaction widespread pandemic viroinformatics approach tlr3 shows tertiary structures specific linker research sought putative epitopes protective potency pet28a (+)) overall investigation multiple epitopes md simulation laboratory analysis ii epitopes hiv ); gc content four mhc exploratory algorithms examining hiv eight mhc docking analysis devise multi cell interaction c terminal assisted screening 100ns ).
Tags:	Add Tag No Tags, Be the first to tag this record!

Cannot write session to /tmp/vufind_sessions/sess_g21e9cd8g55410io9fopnb8laj